NRC vs. PLTK, CRTO, PRG, CTOS, DGNX, MPLN, ETWO, EVH, YEXT, and TIXT
Should you be buying National Research stock or one of its competitors? The main competitors of National Research include Playtika (PLTK), Criteo (CRTO), Aaron's (PRG), Custom Truck One Source (CTOS), Diginex (DGNX), MultiPlan (MPLN), E2open Parent (ETWO), Evolent Health (EVH), Yext (YEXT), and Telus Digital (TIXT). These companies are all part of the "business services" industry.
National Research vs. Its Competitors
National Research (NASDAQ:NRC) and Playtika (NASDAQ:PLTK) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.
In the previous week, Playtika had 6 more articles in the media than National Research. MarketBeat recorded 6 mentions for Playtika and 0 mentions for National Research. Playtika's average media sentiment score of 1.74 beat National Research's score of 0.00 indicating that Playtika is being referred to more favorably in the news media.
National Research has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, Playtika has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.
47.3% of National Research shares are owned by institutional investors. Comparatively, 11.9% of Playtika shares are owned by institutional investors. 2.0% of National Research shares are owned by insiders. Comparatively, 5.1% of Playtika shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
National Research has a net margin of 12.78% compared to Playtika's net margin of 3.23%. National Research's return on equity of 83.52% beat Playtika's return on equity.
Playtika has higher revenue and earnings than National Research. Playtika is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.
National Research pays an annual dividend of $0.48 per share and has a dividend yield of 3.2%. Playtika pays an annual dividend of $0.40 per share and has a dividend yield of 10.6%. National Research pays out 63.2% of its earnings in the form of a dividend. Playtika pays out 166.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Playtika has a consensus target price of $7.04, suggesting a potential upside of 86.87%. Given Playtika's stronger consensus rating and higher possible upside, analysts clearly believe Playtika is more favorable than National Research.
Summary
Playtika beats National Research on 10 of the 18 factors compared between the two stocks.
Get National Research News Delivered to You Automatically
Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
National Research Competitors List
Related Companies and Tools
This page (NASDAQ:NRC) was last updated on 9/4/2025 by MarketBeat.com Staff